Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 5.58244 | 80 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 5.82154 | 81 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 5.62433 | 80 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 5.64704 | 79 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 5.74585 | 80 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 5.59706 | 81 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 5.80121 | 82 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 6.05059 | 83 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 6.12486 | 83 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 6.53095 | 86 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 6.2084 | 84 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 6.29441 | 84 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 6.54141 | 86 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 5.82162 | 81 |